Blood Lec

Overview of Blood Cell Production and Hemostasis

Erythropoiesis

  • Starting Point: Begins with hemocytoblasts (stem cells) in red bone marrow.

    • Two types of stem cells emerge:

    • Lymphoid stem cells

      • Produce lymphocytes (one of the five leukocyte types).

    • Myeloid stem cells

      • Produce erythrocytes, platelets, and the remaining four leukocyte types.

Key Stages of Erythropoiesis

  1. Committed Cell: Transition to early erythroblast.

    • Function: Creates ribosomes for hemoglobin production.

  2. Late Erythroblast Stage:

    • Ribosomes utilized for hemoglobin synthesis, incorporating iron.

  3. Normoblast Stage:

    • Hemoglobin accumulation occurs, while cellular components like the nucleus deteriorate.

    • Significance: Nucleus disintegration leads to biconcave shape for erythrocytes, maximizing oxygen transport efficiency.

Reticulocyte Phase

  • Definition: Immature erythrocyte released into the bloodstream.

  • Count: 1-2% of total erythrocytes; reticulocyte count indicates red blood cell production rate.

  • Mature Erythrocyte Lifespan: 100-120 days.

  • Hormone Stimulating Erythropoiesis: Erythropoietin (EPO) primarily produced in kidneys.

Erythrocyte Count Statistics

  • Male Normal Range: 5.1 to 5.8 million cells/mm³.

  • Female Normal Range: 4.3 to 5.1 million cells/mm³.

  • Leukocyte Count: Normal range 4,000 to 11,000 cells/mm³.

  • Platelet Count: 300,000 to 400,000 cells/mm³.

Erythrocyte Destruction and Recycling

  • Components: Breakdown into pigments from heme; recycling of iron predominantly in the liver.

Leukocyte Production (Leukopoiesis)

  • Stem Cell Lines: Lymphoid and myeloid stem cell lines.

    • Only lymphoid stem cells yield lymphocytes.

    • Myeloid stem cells produce the other leukocyte types:

    • Granulocytes: neutrophils, eosinophils, basophils.

    • Monocytes: Become macrophages.

  • Life Span of White Blood Cells:

    • Leukocytes can live from hours to years (monocytes live for months).

  • Stimulating Factors for Leukopoiesis:

    • Cytokines and colony-stimulating factors (from other white blood cells).

Platelet Production (Thrombopoiesis)

  • Type of Process: Thrombopoiesis.

  • Hormone Stimulating Production: Thrombopoietin (mainly from kidneys).

  • Development Process: Megakaryocytes undergo mitosis, breaking into platelets.

  • Lifespan of Platelets: 5-10 days.

Hemostasis: Stopping Bleeding

  • Definition: Hemostasis translates to the stoppage of bleeding, critical during blood vessel injury.

  • Phases: Three overlapping phases:

    1. Vascular Phase: Immediate vasoconstriction (vascular spasm).

    2. Platelet Plug Formation: 15 seconds post-injury, creating a temporary seal.

    3. Coagulation (Blood Clot Formation): Permanent solution, forming fibrin strands to stabilize the plug.

Vascular Phase

  • Mechanism: Smooth muscle contracts to reduce blood flow.

  • Duration: Lasts about 20-30 minutes.

  • Result: Reduces blood loss and allows time for later clotting phases.

Platelet Plug Formation

  • Process initiated by platelets adhering to exposed collagen (from damaged vessel), activating and releasing chemicals (e.g., ADP, thromboxane A2, serotonin) for further aggregation.

  • Function of Released Chemicals:

    • Serotonin: Enhances vascular spasm.

    • ADP: Attracts more platelets.

    • Thromboxane A2: Stimulates both vascular spasm and platelet aggregation.

    • Prostacyclin (PGI2): Produced by healthy endothelial cells, inhibits platelet aggregation to limit the size of the plug.

Coagulation (Blood Clot Formation)

  1. Formation of Prothrombin Activator: Two pathways: intrinsic (internal blood components) and extrinsic (external tissue damage).

  2. Conversion of Prothrombin to Thrombin: Prothrombin activator converts prothrombin enzyme to thrombin.

  3. Conversion of Fibrinogen to Fibrin: Thrombin catalyzes the transformation of soluble fibrinogen into insoluble fibrin strands, forming the clot (heart of the clot).

Clot Stabilization and Retraction

  • Once formed, the clot may undergo contraction (compaction) by contractile proteins in platelets, leading to serum expulsion.

Restoration Process: Fibrinolysis

  • Definition: The breakdown of fibrin.

  • Enzyme Responsible: Plasminogen is activated to plasmin (breaks down fibrin).

  • Role of TPA: Tissue Plasminogen Activator (TPA) released by healthy endothelial cells initiates plasminogen activation.

Summary of Clot Prevention and Removal

  • Prevention of Abnormal Clots: Smooth endothelial lining, rapid blood flow, and presence of anticoagulants (e.g., antithrombin III, heparin).

  • Inhibition of Excessive Clotting: Prostaglandin PGI2 limits platelet aggregation.

  • After Clot Formation and Healing: Plasminogen is incorporated into the clot to be used for fibrinolysis post-healing.

Clinical Conditions

  • Physiological Jaundice: Yellowing due to elevated bilirubin in premature newborns, aiming at inadequate processing by immature liver. Treatment includes phototherapy, stimulating liver maturation for bilirubin processing.

  • Focus on understanding various clinical implications concerning blood cell production disorders and related conditions to enhance practical application knowledge in future discussions and examinations.